loading
Precedente Chiudi:
$32.76
Aprire:
$33.01
Volume 24 ore:
329.62K
Relative Volume:
0.32
Capitalizzazione di mercato:
$1.94B
Reddito:
-
Utile/perdita netta:
$-100.44M
Rapporto P/E:
-15.16
EPS:
-2.22
Flusso di cassa netto:
$-105.32M
1 W Prestazione:
+16.15%
1M Prestazione:
+23.26%
6M Prestazione:
+24.12%
1 anno Prestazione:
-15.39%
Intervallo 1D:
Value
$32.64
$34.50
Intervallo di 1 settimana:
Value
$28.45
$34.50
Portata 52W:
Value
$13.22
$42.20

Structure Therapeutics Inc Adr Stock (GPCR) Company Profile

Name
Nome
Structure Therapeutics Inc Adr
Name
Telefono
(628) 229-9277
Name
Indirizzo
611 GATEWAY BLVD SUITE 223, SOUTH SAN FRANCISCO
Name
Dipendente
183
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
GPCR's Discussions on Twitter

Confronta GPCR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
GPCR
Structure Therapeutics Inc Adr
33.60 1.89B 0 -100.44M -105.32M -2.22
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.43 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
635.39 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
428.27 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
840.73 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
185.48 39.72B 447.02M -1.18B -868.57M -6.1812

Structure Therapeutics Inc Adr Stock (GPCR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-05-02 Iniziato Citigroup Buy
2025-02-28 Iniziato William Blair Outperform
2025-01-08 Iniziato Stifel Buy
2024-12-04 Iniziato H.C. Wainwright Buy
2024-09-23 Iniziato Morgan Stanley Overweight
2024-05-21 Iniziato JP Morgan Overweight
2024-04-09 Iniziato Cantor Fitzgerald Overweight
2023-10-19 Iniziato JMP Securities Mkt Outperform
2023-07-27 Iniziato Piper Sandler Overweight
2023-05-25 Ripresa Jefferies Buy
2023-02-28 Iniziato BMO Capital Markets Outperform
2023-02-28 Iniziato Guggenheim Buy
2023-02-28 Iniziato Jefferies Buy
2023-02-28 Iniziato SVB Securities Outperform
Mostra tutto

Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie

pulisher
Nov 02, 2025

Pier Capital LLC Cuts Stock Holdings in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Nov 02, 2025
pulisher
Oct 31, 2025

Structure Therapeutics (NASDAQ:GPCR) Shares Up 9.2%Still a Buy? - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Analysts Offer Insights on Healthcare Companies: Atricure (ATRC), Tectonic Therapeutic (TECX) and Akebia Therapeutics (AKBA) - The Globe and Mail

Oct 31, 2025
pulisher
Oct 30, 2025

Strong Market Demand and Convenience Drive Buy Rating for Structure Therapeutics - TipRanks

Oct 30, 2025
pulisher
Oct 29, 2025

11,000 Shares in Structure Therapeutics Inc. Sponsored ADR $GPCR Acquired by Allianz Asset Management GmbH - MarketBeat

Oct 29, 2025
pulisher
Oct 29, 2025

Allianz Asset Management GmbH Has $252,000 Stock Holdings in Sarepta Therapeutics, Inc. $SRPT - Defense World

Oct 29, 2025
pulisher
Oct 29, 2025

Allianz Asset Management GmbH Purchases New Holdings in Tarsus Pharmaceuticals, Inc. $TARS - Defense World

Oct 29, 2025
pulisher
Oct 28, 2025

Jazz Pharmaceuticals (NASDAQ: JAZZ) names Ted W. Love, M.D., to board Dec 1, 2025 - Stock Titan

Oct 28, 2025
pulisher
Oct 26, 2025

Structure Therapeutics (NASDAQ:GPCR) Receives Sell (D-) Rating from Weiss Ratings - MarketBeat

Oct 26, 2025
pulisher
Oct 25, 2025

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now? - NewsBreak: Local News & Alerts

Oct 25, 2025
pulisher
Oct 24, 2025

Critical Survey: Alkermes (NASDAQ:ALKS) and Structure Therapeutics (NASDAQ:GPCR) - Defense World

Oct 24, 2025
pulisher
Oct 23, 2025

Analysts Offer Insights on Healthcare Companies: Bausch Health Companies (BHC), Kura Oncology (KURA) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail

Oct 23, 2025
pulisher
Oct 22, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Align Tech (ALGN) and ProQR (PRQR) - The Globe and Mail

Oct 22, 2025
pulisher
Oct 22, 2025

Pacific Heights Asset Management LLC Acquires New Shares in Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Oct 22, 2025
pulisher
Oct 18, 2025

Trading Systems Reacting to (GPCR) Volatility - news.stocktradersdaily.com

Oct 18, 2025
pulisher
Oct 18, 2025

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Wuxi Biologics (Cayman) (OtherWXIBF) and Avalo Therapeutics (AVTX) - The Globe and Mail

Oct 18, 2025
pulisher
Oct 17, 2025

(PDF) Structural basis for chemotype diversity in small molecule GLP-1 receptor agonist drug discovery - researchgate.net

Oct 17, 2025
pulisher
Oct 17, 2025

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cigna (CI), Abbott Laboratories (ABT) and Corbus Pharmaceuticals (CRBP) - The Globe and Mail

Oct 17, 2025
pulisher
Oct 17, 2025

Analysts Offer Insights on Healthcare Companies: Bristol-Myers Squibb (BMY) and Aclaris Therapeutics (ACRS) - The Globe and Mail

Oct 17, 2025
pulisher
Oct 14, 2025

Structure Therapeutics Inc. (GPCR): Investor Outlook With A 142% Potential Upside - DirectorsTalk Interviews

Oct 14, 2025
pulisher
Oct 14, 2025

Analysts Set Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Target Price at $68.67 - Defense World

Oct 14, 2025
pulisher
Oct 14, 2025

Brokerages Set Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) PT at $68.67 - Defense World

Oct 14, 2025
pulisher
Oct 11, 2025

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Structure Therapeutics Inc. Sponsored ADR (NASDAQ:GPCR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 09, 2025

Structure Therapeutics' (GPCR) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 04, 2025

Structure Therapeutics Inc. Sponsored ADR $GPCR Shares Purchased by Signaturefd LLC - Defense World

Oct 04, 2025
pulisher
Oct 04, 2025

Piper Sandler Keeps Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR) - The Globe and Mail

Oct 04, 2025
pulisher
Oct 03, 2025

Citius Oncology (NASDAQ:CTOR) and Structure Therapeutics (NASDAQ:GPCR) Head to Head Survey - Defense World

Oct 03, 2025
pulisher
Oct 01, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading Down 4.3%Should You Sell? - MarketBeat

Oct 01, 2025
pulisher
Oct 01, 2025

ABSSSI Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Glenmark Pharma, Melinta Therapeutics, Sandoz Inc, Paratek Pharma, AbbVie Inc., Allergan PLC, Merck & Co. Inc., Pfizer - The Globe and Mail

Oct 01, 2025
pulisher
Oct 01, 2025

ABSSSI Market to Reach New Heights in Growth by 2034, - openPR.com

Oct 01, 2025
pulisher
Sep 30, 2025

Structure Therapeutics (NASDAQ:GPCR) Trading 5.8% HigherTime to Buy? - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

ETFs Investing in Structure Therapeutics, Inc. Sponsored ADR Stocks - TradingView

Sep 30, 2025
pulisher
Sep 30, 2025

Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense - The Globe and Mail

Sep 30, 2025
pulisher
Sep 30, 2025

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unveiling a Potential 189% Upside in the Biotechnology Sector - DirectorsTalk Interviews

Sep 30, 2025
pulisher
Sep 27, 2025

Banque Pictet & Cie SA Sells 11,365 Shares of Structure Therapeutics Inc. Sponsored ADR $GPCR - MarketBeat

Sep 27, 2025
pulisher
Sep 26, 2025

Gossamer Bio Enters into Option Agreement to Acquire Respira Therapeutics and Its Lead Candidate, RT234, an Inhaled, On‑Demand Vardenafil for Pulmonary Hypertension - BioSpace

Sep 26, 2025
pulisher
Sep 25, 2025

Layoff Tracker: Heidelberg Cuts 75% of Staff After Missed Royalty Payment - BioSpace

Sep 25, 2025
pulisher
Sep 24, 2025

Structure Therapeutics stock rating reiterated at Buy by H.C. Wainwright - Investing.com India

Sep 24, 2025
pulisher
Sep 23, 2025

Interactive Brokers Group, Inc. $IBKR Shares Acquired by Swedbank AB - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Sumitomo Mitsui DS Asset Management Company Ltd Makes New Investment in Confluent, Inc. $CFLT - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Exchange Traded Concepts LLC Buys 1,054 Shares of TKO Group Holdings, Inc. $TKO - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Has $3.42 Million Stock Position in Annaly Capital Management Inc $NLY - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

MongoDB, Inc. $MDB Shares Acquired by IFM Investors Pty Ltd - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Wealth Enhancement Advisory Services LLC Grows Stock Holdings in VanEck Semiconductor ETF $SMH - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Voya Investment Management LLC Buys 1,696 Shares of PriceSmart, Inc. $PSMT - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Voya Investment Management LLC Lowers Stock Position in Dutch Bros Inc. $BROS - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

Vanguard Total International Bond ETF $BNDX Shares Bought by Exchange Traded Concepts LLC - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Boosts Position in Evergy Inc. $EVRG - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

IFM Investors Pty Ltd Grows Holdings in Trimble Inc. $TRMB - Defense World

Sep 23, 2025
pulisher
Sep 23, 2025

UnitedHealth Group Incorporated $UNH Shares Acquired by Exchange Traded Concepts LLC - Defense World

Sep 23, 2025

Structure Therapeutics Inc Adr Azioni (GPCR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.91
price up icon 1.73%
$29.21
price up icon 1.73%
$103.13
price up icon 1.63%
$104.19
price up icon 0.28%
biotechnology ONC
$315.06
price up icon 0.87%
$184.99
price down icon 0.56%
Capitalizzazione:     |  Volume (24 ore):